Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia

BACKGROUND: Inhaled nitric oxide (NO) is a selective pulmonary vasodilator. In-vitro studies report that NO donors can inhibit replication of SARS-CoV-2. This multicenter study evaluated the feasibility and effects of high-dose inhaled NO in non-intubated spontaneously breathing patients with Corona...

Descripción completa

Detalles Bibliográficos
Autores principales: Safaee Fakhr, Bijan, Di Fenza, Raffaele, Gianni, Stefano, Wiegand, Steffen B., Miyazaki, Yusuke, Araujo Morais, Caio C., Gibson, Lauren E., Chang, Marvin G., Mueller, Ariel L., Rodriguez-Lopez, Josanna M., Ackman, Jeanne B., Arora, Pankaj, Scott, Louie K., Bloch, Donald B., Zapol, Warren M., Carroll, Ryan W., Ichinose, Fumito, Berra, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361002/
https://www.ncbi.nlm.nih.gov/pubmed/34400339
http://dx.doi.org/10.1016/j.niox.2021.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361002/
https://www.ncbi.nlm.nih.gov/pubmed/34400339
http://dx.doi.org/10.1016/j.niox.2021.08.003

Ejemplares similares